NYSEMKT: CANF
Can Fite Biopharma Ltd Stock Ownership - Who owns Can Fite Biopharma?

Insider buying vs selling

Have Can Fite Biopharma Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CANF insiders and whales buy or sell their stock.

CANF Shareholders

What type of owners hold Can Fite Biopharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Sabby Management LLC0.04%1,406,050$6.03MInstitution
Rhumbline Advisers0.00%57,932$248.53kInstitution
Bnp Paribas Financial Markets0.00%16,585$71.15kInstitution
Bogart Wealth LLC0.00%15,045$64.54kInstitution
Morgan Stanley0.00%12,555$53.86kInstitution
Captrust Financial Advisors0.00%11,375$48.80kInstitution
Two Sigma Securities LLC0.00%10,642$45.65kInstitution
Fifth Third Bancorp0.00%3,000$12.87kInstitution
Wells Fargo Company0.00%2,700$11.58kInstitution
Ubs Group Ag0.00%1,308$5.61kInstitution

1 of 2

CANF vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CANF100.00%0.00%
ARTL1.64%41.30%
ONCO1.65%98.35%
VRAX1.45%0.00%
MLEC2.02%97.98%

Can Fite Biopharma Stock Ownership FAQ

Who owns Can Fite Biopharma?

Can Fite Biopharma (NYSEMKT: CANF) is owned by 116.34% institutional shareholders, 0.00% Can Fite Biopharma insiders, and 0.00% retail investors. Sabby Management LLC is the largest individual Can Fite Biopharma shareholder, owning 1.41M shares representing 106.32% of the company. Sabby Management LLC's Can Fite Biopharma shares are currently valued at $5.60M.

If you're new to stock investing, here's how to buy Can Fite Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.